Zurich Cantonal Bank
INDV icon

Zurich Cantonal Bank’s Indivior Pharmaceuticals INDV Stock Holding History

Zurich Cantonal Bank’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.02M Sell
49,117
-473
-1% -$17.2K ﹤0.01% 1136
2026
Q1 		$1.51M Buy
49,590
+11,507
+30% +$380K ﹤0.01% 1193
2025
Q4 		$1.37M Sell
38,083
-591
-2% -$18K ﹤0.01% 1160
2025
Q3 		$932K Sell
38,674
-6,667
-15% -$140K ﹤0.01% 1332
2025
Q2 		$674K Sell
45,341
-106
-0.2% -$1.24K ﹤0.01% 1470
2025
Q1 		$426K Buy
45,447
+751
+2% +$7.89K ﹤0.01% 1692
2024
Q4 		$573K Buy
44,696
+3,369
+8% +$34.7K ﹤0.01% 1546
2024
Q3 		$408K Buy
41,327
+1,888
+5% +$22.1K ﹤0.01% 1687
2024
Q2 		$618K Sell
39,439
-203
-0.5% -$3.66K ﹤0.01% 1342
2024
Q1 		$848K Buy
39,642
+135
+0.3% +$2.54K ﹤0.01% 1149
2023
Q4 		$597K Sell
39,507
-89
-0.2% -$1.58K ﹤0.01% 1395
2023
Q3 		$860K Buy
39,596
+5,365
+16% +$122K ﹤0.01% 1054
2023
Q2 		$793K Buy
+34,231
New +$785K ﹤0.01% 1067

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Zurich Cantonal Bank's INDV Position: Q2 2026 in Review

Zurich Cantonal Bank reduced its Indivior Pharmaceuticals (INDV) stake by 0.95% in Q2 2026, selling an estimated $17.2K and leaving 49,117 shares worth $2.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1136.

Zurich Cantonal Bank first reported a position in INDV in Q2 2023 and has held it in 13 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Zurich Cantonal Bank held 49,117 shares of Indivior Pharmaceuticals worth $2.02M as of Q2 2026.
  • Zurich Cantonal Bank sold 473 Indivior Pharmaceuticals shares in Q2 2026, an estimated $17.2K.
  • Indivior Pharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1136 holding.
  • Zurich Cantonal Bank first reported a position in Indivior Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.